title: Synthetic cannabis.
authors.affiliation: Department of Clinical Pharmacology, St. Olav University Hospital, Norway. andreas.westin@legemidler.no
authors.forename: Andreas Austgulen
authors.initials: AA
authors.lastname: Westin
authors.forename: Wenche Rødseth
authors.initials: WR
authors.lastname: Brede
authors.forename: Ketil Arne
authors.initials: KA
authors.lastname: Espnes
mesh_terms: D002186:Cannabinoids / Q000009:adverse effects / Q000032:analysis* / Q000494:pharmacology; D002188:Cannabis / Q000009:adverse effects*; D015198:Designer Drugs / Q000009:adverse effects / Q000032:analysis* / Q000494:pharmacology; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects / Q000032:analysis / Q000494:pharmacology; D007211:Indoles / Q000009:adverse effects / Q000032:analysis* / Q000494:pharmacology; D008385:Marijuana Smoking / Q000009:adverse effects; D009281:Naphthalenes / Q000009:adverse effects / Q000032:analysis* / Q000494:pharmacology
chemical_list: D002186:Cannabinoids; D015198:Designer Drugs; D013287:Illicit Drugs; D007211:Indoles; D009281:Naphthalenes; C552597:1-pentyl-3-(1-naphthoyl)indole